'Shovel-Ready' applications of stem cell advances for pediatric heart disease

Current Opinion in Pediatrics

Volumn 24, Issue 5, 2012, Pages 577-583

  Files, Matthew D ^a   Boucek, Robert J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cardiac progenitor cells; disease modeling; induced pluripotent stem cells; pediatric heart failure

Indexed keywords

AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIAC PROGENITOR CELL; CELL DIFFERENTIATION; CELL REGENERATION; CELL THERAPY; CHILDHOOD DISEASE; CLINICAL TRIAL (TOPIC); FIBROBLAST; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE FUNCTION; HUMAN; INFANT DISEASE; LEOPARD SYNDROME; LONG QT SYNDROME; NONHUMAN; PATIENT SAFETY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT INDICATION;

CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; GUIDED TISSUE REGENERATION; HEART DEFECTS, CONGENITAL; HEART FAILURE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFANT; INFANT, NEWBORN; MALE; MYOCYTES, CARDIAC; POSTOPERATIVE COMPLICATIONS; STEM CELL TRANSPLANTATION;

EID: 84866346595     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328357a4cf     Document Type: Review

References (51)

1. Kochanek KD, Kirmeyer SE, Martin JA, et al. Annual summary of vital statistics: 2009. Pediatrics 2012; 129:338-348.
2. Hsu DT, Pearson GD. Heart failure in children: part I: history, etiology, and pathophysiology. Circ Heart Fail 2009; 2:63-70.
3. Hsu DT, Pearson GD. Heart failure in children: part II: diagnosis, treatment, and future directions. Circ Heart Fail 2009; 2:490-498.
4. Rupp S, Zeiher AM, Dimmeler S, et al. A regenerative strategy for heart failure in hypoplastic left heart syndrome: intracoronary administration of autologous bone marrow-derived progenitor cells. J Heart Lung Transplant 2010; 29: 574-577.
5. Feinstein JA, Benson DW, Dubin AM, et al. Hypoplastic left heart syndrome. J Am Coll Cardiol 2012; 59:S1-S42.
6. Shaddy RE, Fuller TC. The sensitized pediatric heart transplant candidate: causes, consequences, and treatment options. Pediatr Transplant 2005; 9:208-214.
7. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114:763-776.
8. Urbanek K, Quaini F, Tasca G, et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A 2003; 100:10440-10445.
9. Kaushal S, Jacobs JP, Gossett JG, et al. Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure: opportunities and challenges. Cardiol Young 2009; 19 (Suppl 2):74-84.
10. Leri A, Kajstura J, Anversa P. Role of cardiac stem cells in cardiac patho-physiology: a paradigm shift in human myocardial biology. Circ Res 2011; 109:941-961.
11. Shah AP, Youngquist ST, McClung CD, et al. Markers of progenitor cell recruitment and differentiation rise early during ischemia and continue during resuscitation in a porcine acute ischemia model. J Interferon Cytokine Res 2011; 31:509-513.
12. Laflamme MA, Murry CE. Heart regeneration. Nature 2011; 473:326-335.
13. Smart N, Bollini S, Dubé KN, et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature 2011; 474:640-644.
14. D'Amario D, Fiorini C, Campbell PM, et al. Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res 2011; 108:857-861.
15. Mishra R, Vijayan K, Colletti EJ, et al. Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation 2011; 123:364-373.
16. Shaddy RE, Boucek MM, Hsu DT, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 2007; 298:1171-1179.
17. Chamuleau SAJ, Vrijsen KR, Rokosh DG, et al. Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells. Neth Heart J 2009; 17:199-207.
18. Wu J, Li J, Zhang N, Zhang C. Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation. Basic Res Cardiol 2011; 106:317-324.
19. Kattman SJ, Koonce CH, Swanson BJ, Anson BD. Stem cells and their derivatives: a renaissance in cardiovascular translational research. J Cardio-vasc Transl Res 2011; 4:66-72.
20. Lacis A, Bergmane I, Ozolins V, et al. First results of using stem cell transplantation for pediatric patients in case of dilated cardiomyopathy. Acta Chirurgica Latviensis Versita 2010; 10:76-79.
21. Timmers L, Lim SK, Arslan F, et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 2007; 1:129-137.
22. Loffredo FS, Steinhauser ML, Gannon J, Lee RT. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 2011; 8:389-398.
23. Bolli R, Chugh AR, D'Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011; 378:1847-1857.
24. Rota M, Padin-Iruegas ME, Misao Y, et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 2008; 103:107-116.
25. Tang XL, Rokosh G, Sanganalmath SK, et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 2010; 121:293-305.
26. Makkar RR, Smith RR, Cheng K, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012; 379:1-10.
27. Smith RR, Barile L, Cho HC, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007; 115:896-908.
28. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25:1015-1024.
29. Bernstein HS, Srivastava D. Stem cell therapy for cardiac disease. Pediatr Res 2012; 71:491-499.
30. He J-Q, Vu DM, Hunt G, et al. Human cardiac stem cells isolated from atrial appendages stably express c-kit. PLoS ONE 2011; 6:e27719.
31. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-676.
32. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872.
33. Huangfu D, Osafune K, Maehr R, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008; 26:1269-1275.
34. Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009; 4:381-384.
35. Anokye-Danso F, Trivedi CM, Juhr D, et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011; 8:376-388.
36. Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7:618-630.
37. Ieda M, Fu J-D, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010;142:375-386.
38. Qian L, Huang Y, Spencer CI, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012; 485:593-598.
39. Jayawardena TM, Egemnazarov B, Finch EA, et al. MicroRNA-mediatedin vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res 2012; 110:1465-1473.
40. Oh Y, Wei H, Ma D, et al. Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine. Heart 2012; 98:443-449.
41. Moretti A, Bellin M, Welling A, et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010; 363:1397-1409.
42. Sun N, Yazawa M, Liu J, et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med 2012; 4:ra47.
43. Carvajal-Vergara X, Sevilla A, D'Souza SL, et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 2010;465:808-812.
44. Shi Y, Kirwan P, Smith J, et al. A human stem cell model of early Alzheimer's disease pathology in Down syndrome. Sci Transl Med 2012; 4:124ra29-9.
45. Ng K-M, Lee Y-K, Lai W-H, et al. Exogenous expression of human apoA-I enhances cardiac differentiation of pluripotent stem cells. PLoS ONE 2011; 6:e19787.
46. Kreutziger KL, Murry CE. Engineered human cardiac tissue. Pediatr Cardiol 2011; 32:334-341.
47. Lahti AL, Kujala VJ, Chapman H, et al. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis Models Mech 2012, 5:220-230.
48. Zimmermann W-H, Cesnjevar R. Cardiac tissue engineering: implications for pediatric heart surgery. Pediatr Cardiol 2009; 30:716-723.
49. Tulloch NL, Muskheli V, Razumova MV, et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 2011; 109:47-59.
50. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004; 22:1282-1289.
51. Xue T, Cho HC, Akar FG, et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 2005; 111:11-20.